Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 4;398(10303):819-821.
doi: 10.1016/S0140-6736(21)01729-3. Epub 2021 Aug 6.

Optimising SARS-CoV-2 vaccination schedules

Cristobal Belda-Iniesta  1
Affiliations
Comment

Optimising SARS-CoV-2 vaccination schedules

Cristobal Belda-Iniesta. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Palgen J-L, Feraoun Y, Dzangué-Tchoupou G, et al. Optimize prime/boost vaccine strategies: trained immunity as a new player in the game. Front Immunol. 2021;12:554. - PMC - PubMed
    1. Liu X, Shaw RH, Stuart ASV, et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021 doi: 10.1016/S0140-6736(21)01694-9. published online Aug 6. - DOI - PMC - PubMed
    1. Borobia AM, Carcas AJ, Pérez-Olmeda M. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 2021;398:121–130. - PMC - PubMed
    1. Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467–478. - PMC - PubMed
    1. Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–593. - PubMed

Substances